FLNA 8-K: Fda approval
Filana Therapeutics
Filed with the SEC on · accession 0001171843-26-007150
FLNA filed a 8-K (current report) with the SEC on Nov 5, 2026. Filana Therapeutics announced that the FDA lifted the clinical hold on its IND for simufilam in TSC-related epilepsy, allowing the company to advance a planned Phase 2a study with patient screening expected to begin by Q1 2027.
Summary of the filing
Filana Therapeutics announced that the FDA lifted the clinical hold on its IND for simufilam in TSC-related epilepsy, allowing the company to advance a planned Phase 2a study with patient screening expected to begin by Q1 2027. The company also reported Q3 2026 financial results with a net loss of $10.7 million and $47.0 million in cash.
Key details
✦ Ask GOAX AI about this filing — what it means for FLNA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for FLNA?
Click hereFrequently asked questions
What did FLNA file with the SEC on Nov 5, 2026?
FLNA filed a 8-K (Fda approval). Filana Therapeutics announced that the FDA lifted the clinical hold on its IND for simufilam in TSC-related epilepsy, allowing the company to advance a planned Phase 2a study with patient screening expected to begin by Q1 2027. The company also reported Q3 2026 financial results with a net loss of $10.7 million and $47.0 million in cash.
What does a fda approval mean for FLNA stock?
For a small biotech one drug can be most of the company’s value. Approval opens sales; a rejection (complete response letter) can delay it by years.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other FLNA SEC filings
Get alerts when FLNA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days